US Stock MarketDetailed Quotes

Atrium Therapeutics (RNA)

Watchlist
  • 13.790
  • -0.200-1.43%
Trading Apr 8 10:27 ET
213.95MMarket Cap-4.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atrium Therapeutics (RNA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(FY)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.37%-41.13M
-132.99%-19.25M
-139.99%-22.55M
-8.26M
56.39M
Net income from continuing operations
-97.04%-49.5M
-153.09%-29.14M
-293.45%-25.12M
---11.51M
---6.39M
Operating gains losses
--140K
----
----
----
--195K
Depreciation and amortization
87.79%323K
110.34%122K
24.64%172K
--58K
--138K
Deferred tax
-101.19%-142K
-99.35%34K
--11.91M
--5.27M
--0
Other non cash items
180.39%572K
324.62%276K
--204K
--65K
----
Change In working capital
98.45%-200K
278.38%5.76M
-121.51%-12.89M
---3.23M
--59.94M
-Change in receivables
--0
--0
-45.82%751K
--0
--1.39M
-Change in prepaid assets
-178.31%-1.05M
-501.47%-273K
-447.83%-378K
--68K
---69K
-Change in payables and accrued expense
47,363.33%14.18M
3,142.50%9.08M
96.41%-30K
--280K
---836K
-Change in other current assets
---1.31M
-1,588.64%-1.31M
--0
--88K
----
-Change in other current liabilities
--0
--0
--574K
--252K
--0
-Change in other working capital
12.96%-12.02M
55.68%-1.74M
-123.22%-13.81M
---3.92M
--59.45M
Cash from discontinued investing activities
Operating cash flow
-82.37%-41.13M
-132.99%-19.25M
-139.99%-22.55M
---8.26M
--56.39M
Investing cash flow
Cash flow from continuing investing activities
-443.23%-1.45M
-303.21%-879K
16.88%-266K
-218K
-320K
Net PPE purchase and sale
-443.23%-1.45M
-303.21%-879K
16.88%-266K
---218K
---320K
Cash from discontinued investing activities
Investing cash flow
-443.23%-1.45M
-303.21%-879K
16.88%-266K
---218K
---320K
Financing cash flow
Cash flow from continuing financing activities
86.57%42.57M
137.37%20.13M
140.70%22.82M
8.48M
-56.07M
Net other financing activities
86.57%42.57M
137.37%20.13M
140.70%22.82M
--8.48M
---56.07M
Cash from discontinued financing activities
Financing cash flow
86.57%42.57M
137.37%20.13M
140.70%22.82M
--8.48M
---56.07M
Net cash flow
Beginning cash position
--0
--0
--0
--0
--0
End cash Position
--0
--0
--0
--0
--0
Free cash flow
-86.57%-42.57M
-137.37%-20.13M
-140.70%-22.82M
---8.48M
--56.07M
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2025(Q4)Dec 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(FY)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.37%-41.13M-132.99%-19.25M-139.99%-22.55M-8.26M56.39M
Net income from continuing operations -97.04%-49.5M-153.09%-29.14M-293.45%-25.12M---11.51M---6.39M
Operating gains losses --140K--------------195K
Depreciation and amortization 87.79%323K110.34%122K24.64%172K--58K--138K
Deferred tax -101.19%-142K-99.35%34K--11.91M--5.27M--0
Other non cash items 180.39%572K324.62%276K--204K--65K----
Change In working capital 98.45%-200K278.38%5.76M-121.51%-12.89M---3.23M--59.94M
-Change in receivables --0--0-45.82%751K--0--1.39M
-Change in prepaid assets -178.31%-1.05M-501.47%-273K-447.83%-378K--68K---69K
-Change in payables and accrued expense 47,363.33%14.18M3,142.50%9.08M96.41%-30K--280K---836K
-Change in other current assets ---1.31M-1,588.64%-1.31M--0--88K----
-Change in other current liabilities --0--0--574K--252K--0
-Change in other working capital 12.96%-12.02M55.68%-1.74M-123.22%-13.81M---3.92M--59.45M
Cash from discontinued investing activities
Operating cash flow -82.37%-41.13M-132.99%-19.25M-139.99%-22.55M---8.26M--56.39M
Investing cash flow
Cash flow from continuing investing activities -443.23%-1.45M-303.21%-879K16.88%-266K-218K-320K
Net PPE purchase and sale -443.23%-1.45M-303.21%-879K16.88%-266K---218K---320K
Cash from discontinued investing activities
Investing cash flow -443.23%-1.45M-303.21%-879K16.88%-266K---218K---320K
Financing cash flow
Cash flow from continuing financing activities 86.57%42.57M137.37%20.13M140.70%22.82M8.48M-56.07M
Net other financing activities 86.57%42.57M137.37%20.13M140.70%22.82M--8.48M---56.07M
Cash from discontinued financing activities
Financing cash flow 86.57%42.57M137.37%20.13M140.70%22.82M--8.48M---56.07M
Net cash flow
Beginning cash position --0--0--0--0--0
End cash Position --0--0--0--0--0
Free cash flow -86.57%-42.57M-137.37%-20.13M-140.70%-22.82M---8.48M--56.07M
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.54%
Sample Name
Sample Code
 +11.09%
Sample Name
Sample Code
 +9.54%
4
United Sts Brent Oil Fd Lp Unit
BNO
+7.49%
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+7.01%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.21%
Sample Name
Sample Code
 +13.65%
Sample Name
Sample Code
 +13.56%
4
Chagee Holdings
CHA
+12.46%
5
Kingsoft Cloud
KC
+11.53%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -